Hepatic CEBPA was suggested to promote hepatic lipogenesis (18, 19), while hepatocyte CEBPA knockout potentiated fatty liver in some currently examined experimental MASH conditions, raising new concerns regarding the lipid-lowering role of hepatocyte CEBPA. This evidence concerns the gene CEBPA and metabolic dysfunction-associated steatohepatitis.